Elevated DPP4 activity and concentration have been implicated in several metabolic disorders, including obesity, FL, type 2 diabetes mellitus (T2DM), and coronary artery disease (CAD) [32–35]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.